Today: 1 July 2026
Xero share price drops 4.6% as ASX tech sell-off drags on — what to watch next
24 February 2026
1 min read

Xero share price drops 4.6% as ASX tech sell-off drags on — what to watch next

SYDNEY, Feb 24, 2026, 18:31 AEDT — After-hours

  • Xero (ASX: XRO) dropped 4.6% on Tuesday, lagging behind as the broader market barely moved.
  • Australian tech stocks remained under pressure this day, and software names took some of the heaviest hits.
  • Wednesday brings fresh inflation numbers, with traders also tracking upcoming earnings updates this reporting season.

Xero Ltd (ASX: XRO) finished Tuesday down 4.6% at A$71.84, slipping to A$71.45 during the session. The Wellington-headquartered accounting software company’s market cap stands around A$12.2 billion.

The S&P/ASX 200 barely budged, closing at 9,022—a dip of just 0.04%—after briefly dipping under the 9,000 mark earlier in the day.

Timing’s in focus for traders. Major software names have been weighing on the market, and once again, Xero finds itself pulled into the debate over how to value growth stocks when sentiment sours.

The S&P/ASX 200 Tech Index slipped around 3% in the afternoon session. Shares in TechnologyOne lost 4.5%, WiseTech Global dropped 3%, and Xero, at its lowest, traded down roughly 3.7%. Market Index flagged a heavy calendar for Wednesday, with WiseTech and Woolworths among those set to deliver results.

Wall Street’s recent dip, Tony Sycamore of IG said, shows investors scrambling yet again to identify who might get hit next by the AI shakeup—likening the hunt to a frantic game of “whack-a-mole.” On Wednesday, Australia drops its January monthly consumer price index (CPI) figure at 11:30 a.m. AEDT. That inflation readout has the potential to jolt both rate expectations and valuations on future earnings. ig.com

Xero put out a market update Monday, detailing several key dates for FY27, which wraps at the end of March 2027. The company scheduled its annual meeting for Aug. 27. Half-year numbers are due Nov. 12, with full-year results following on May 20, 2027. Director nominations close July 9.

Reuters reports the company targets small businesses with its suite of cloud-based solutions for accounting, payroll, and payments. Its portfolio features brands such as Planday, Hubdoc, Syft, TaxCycle, and Tickstar.

Yet risks still linger. Software names worldwide have taken a beating, with investors weighing how fast AI might erode pieces of the stack; IBM’s U.S. shares dropped 13% on Monday after Anthropic announced its Claude Code tool can modernise COBOL systems.

Xero usually rebounds alongside the sector when tech selling slows down. But if the pressure on tech continues, it’s often the first to take a hit as investors trim positions—still caught in the crossfire of the ongoing debate over growth and valuation.

The big date for Xero is May 14, when it’s set to report FY26 full-year numbers for the period ending March 31.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Nifty Eyes 24,000 as Global Markets Lean Higher
    June 30, 2026, 11:04 PM EDT. Nifty could try for 24,000 after positive sessions in US markets, but global cues are still mixed. Wall Street ended Tuesday with gains-Dow, S&P 500 and Nasdaq added 0.2% to 1.5%. Dow and S&P 500 are up about 9% so far this year, Nasdaq leads with a 13% jump. GIFT Nifty hints at a subdued start for Indian shares. Geopolitical risks weigh on trade, with US Vice President JD Vance calling the next few weeks critical for US-Iran dynamics. Qatar said only technical-level talks are happening, not high-level meetings between the US and Iran. Investor caution stays high with geopolitical tensions in focus.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop